Research and Markets: CNS Therapeutics - Global Strategic Business Report 2015-2020

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/bt5t3w/cns_therapeutics) has announced the addition of the "CNS Therapeutics - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report profiles 145 companies including many key and niche players such as:

  • AbbVie Inc. (USA)
  • Actavis Plc. (Ireland)
  • Alkermes Plc. (Ireland)
  • Amneal Pharmaceuticals, LLC (USA)
  • Aspen Pharmacare Holdings Limited (Australia)
  • AstraZeneca Plc (UK)
  • BIAL Group (Portugal)
  • Boehringer Ingelheim GmbH (Germany)
  • Bristol-Myers Squibb (USA)
  • Dainippon Sumitomo Pharma Co., Ltd. (Japan)
  • Eisai Co., Ltd. (Japan)
  • Eli Lilly and Co. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fabre-Kramer Pharmaceuticals, Inc. (USA)
  • GlaxoSmithKline (UK)
  • H. Lundbeck A/S (Denmark)
  • Johnson & Johnson (USA)
  • Janssen Pharmaceuticals, Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Neurocrine Biosciences, Inc. (USA)
  • Novartis AG (Switzerland)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Pfizer, Inc. (USA)
  • Sanofi S.A (France)
  • Shire Plc (UK)
  • Sunovion Pharmaceuticals, Inc. (USA)
  • Takeda Pharmaceutical Co., Ltd. (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • UCB Group (Belgium)

Key Topics Covered:

1. INDUSTRY OVERVIEW

2. NOTEWORTHY MARKET TRENDS, GROWTH DRIVERS & ISSUES

3. MARKET ANALYSIS BY THERAPEUTIC CATEGORIES

4. PRODUCT OVERVIEW

5. PRODUCT INTRODUCTIONS/INNOVATIONS & R&D BREAKTHROUGHS

6. RECENT INDUSTRY ACTIVITY

7. FOCUS ON SELECT GLOBAL PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 145 (including Divisions/Subsidiaries - 172)

  • The United States (69)
  • Canada (11)
  • Japan (14)
  • Europe (47)
  • - France (4)
  • - Germany (9)
  • - The United Kingdom (11)
  • - Italy (1)
  • - Rest of Europe (22)
  • Asia-Pacific (Excluding Japan) (23)
  • Middle East (7)
  • Africa (1)

For more information visit http://www.researchandmarkets.com/research/bt5t3w/cns_therapeutics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Central Nervous System

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Central Nervous System